Coming therapies: adefovir
Related Experiment Video
Updated: Oct 18, 2026

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
Published on: July 14, 2023
1University of Bari, Italy.
Abstract:
Adefovir dipivoxil, an acyclic nucleotide phosphonate analogue, demonstrates a potent and sustained antiviral activity. Its long half-life allows once daily administration and due to the observed reduction in L-carnitine plasma levels, supplementation with L-carnitine is required. Clinical evidence indicates adefovir dipivoxil can be used as first-line therapy. In addition, due to the sensitivity of drug resistant strains to adefovir dipivoxil, it also has a role in second-line or multi-drug salvage regimens. Adefovir dipivoxil is safe and well tolerated for only short periods of treatment.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Drug Therapy
Antianxiety Medications
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Inhibitors of Virion Maturation and Assembly
